Medistim ASA reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was NOK 133.79 million compared to NOK 129.26 million a year ago. Net income was NOK 24.38 million compared to NOK 25.67 million a year ago.

Basic earnings per share from continuing operations was NOK 1.33 compared to NOK 1.41 a year ago. Diluted earnings per share from continuing operations was NOK 1.33 compared to NOK 1.4 a year ago.